Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial
Authors
Keywords
-
Journal
CIRCULATION
Volume 121, Issue 24, Pages 2645-2653
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2010-06-08
DOI
10.1161/circulationaha.109.899211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of the SYNTAX score in the Syntax study
- (2010) Patrick Serruys et al. EuroIntervention
- Unprotected Left Main Stenting in the Real World
- (2009) Beatriz Vaquerizo et al. CIRCULATION
- Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease
- (2009) Julinda Mehilli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
- (2009) Patrick W. Serruys et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting
- (2008) Timo H. Mäkikallio et al. ANNALS OF MEDICINE
- Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery
- (2008) Chuntao Wu et al. ANNALS OF THORACIC SURGERY
- Nonrandomized Comparison of Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention for the Treatment of Unprotected Left Main Coronary Artery Disease in Octogenarians
- (2008) Josep Rodés-Cabau et al. CIRCULATION
- Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry
- (2008) A. Chieffo et al. EUROPEAN HEART JOURNAL
- Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT)
- (2008) E. Meliga et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Comparison of Coronary Artery Bypass Surgery and Percutaneous Drug-Eluting Stent Implantation for Treatment of Left Main Coronary Artery Stenosis
- (2008) Anthony J. White et al. JACC-Cardiovascular Interventions
- Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization
- (2008) Pawel E. Buszman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies
- (2008) Hisato Takagi et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
- (2008) Ki Bae Seung et al. NEW ENGLAND JOURNAL OF MEDICINE
- A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease
- (2007) Giuseppe G.L. Biondi-Zoccai et al. AMERICAN HEART JOURNAL
- Comparison of Percutaneous Versus Surgical Revascularization of Severe Unprotected Left Main Coronary Stenosis in Matched Patients
- (2007) Sorin J. Brener et al. AMERICAN JOURNAL OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started